Literature DB >> 3031452

Localization of specific topoisomerase I interactions within the transcribed region of active heat shock genes by using the inhibitor camptothecin.

D S Gilmour, S C Elgin.   

Abstract

Camptothecin stabilizes the topoisomerase I-DNA covalent intermediate that forms during the relaxation of torsionally strained DNA. By mapping the position of the resultant DNA nicks, we analyzed the distribution of the covalent intermediates formed on heat shock genes in cultured Drosophila melanogaster cells. Topoisomerase I was found to interact with the transcriptionally active genes hsp22, hsp23, hsp26, and hsp28 after heat shock but not with the inactive genes before heat shock. The interaction occurred predominantly within the transcribed region, with specific sites occurring on both the transcribed and nontranscribed strands of the DNA. Little interaction was seen with nontranscribed flanking sequences. Camptothecin only partially inhibited transcription of the hsp28 gene during heat shock, causing a reduced level of transcripts which were nonetheless full length. Topoisomerase I also interacted with the DNA throughout the transcriptionally active hsp83 gene, including an intron, in both heat-shocked and non-heat-shocked cells. The results point to a dynamic set of interactions at the active locus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031452      PMCID: PMC365050          DOI: 10.1128/mcb.7.1.141-148.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination.

Authors:  P Bullock; J J Champoux; M Botchan
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

2.  Gyration is required for 5S RNA transcription from a chromatin template.

Authors:  E B Kmiec; M Ryoji; A Worcel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  Both DNA topoisomerases I and II relax 2 micron plasmid DNA in living yeast cells.

Authors:  R A Saavedra; J A Huberman
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

4.  In vivo interactions of RNA polymerase II with genes of Drosophila melanogaster.

Authors:  D S Gilmour; J T Lis
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

5.  In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction.

Authors:  M Berrios; N Osheroff; P A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Novobiocin blocks the Drosophila heat shock response.

Authors:  S Han; A Udvardy; P Schedl
Journal:  J Mol Biol       Date:  1985-05-05       Impact factor: 5.469

7.  Topoisomerase I interacts with transcribed regions in Drosophila cells.

Authors:  D S Gilmour; G Pflugfelder; J C Wang; J T Lis
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

8.  Multiple forms and cellular localization of Drosophila DNA topoisomerase II.

Authors:  R A Heller; E R Shelton; V Dietrich; S C Elgin; D L Brutlag
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

9.  Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II.

Authors:  T Goto; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  41 in total

1.  In vitro analysis of a type I DNA topoisomerase activity from cultured tobacco cells.

Authors:  A D Cole; S Heath-Pagliuso; A Baich; E B Kmiec
Journal:  Plant Mol Biol       Date:  1992-05       Impact factor: 4.076

2.  Topoisomerase I is preferentially associated with normal SV40 replicative intermediates, but is associated with both replicating and nonreplicating SV40 DNAs which are deficient in histones.

Authors:  J J Champoux
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

3.  In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.

Authors:  C Pondarré; D Strumberg; A Fujimori; R Torres-León; Y Pommier
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

4.  Topoisomerase I is associated with the regulatory region of transcriptionally active SV 40 minichromosomes.

Authors:  Y S Vassetzky; V V Bakayev; A G Kalandadze; S V Razin
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

5.  A DNA topoisomerase I inhibitor blocks the differentiation of rat granulosa cells induced by follicle-stimulating hormone.

Authors:  J L Barañao; M A Bley; F D Batista; G C Glikin
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

6.  Topoisomerase I-mediated integration of hepadnavirus DNA in vitro.

Authors:  H P Wang; C E Rogler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature.

Authors:  S Krogh; U H Mortensen; O Westergaard; B J Bonven
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

8.  Sequence dependent modulating effect of camptothecin on the DNA-cleaving activity of the calf thymus type I topoisomerase.

Authors:  I I Gromova; V L Buchman; R A Abagyan; A V Ulyanov; I B Bronstein
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

9.  Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.

Authors:  J Schaak; P Schedl; T Shenk
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

10.  The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.

Authors:  S E Porter; J J Champoux
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.